iwAL 2018 Session VIII
Current & Future Challenges in Trial Design
From the final session of iwAL 2018, there are e-learning webcasts featuring Elihu Estey, MD, Mark Levis, MD, PhD, and Jane Liang-White, PhD, who gave presentations on the challenges faced when designing clinical trials.
Presentations
Trial Design and Endpoints
Elihu Estey, MD
Seattle Cancer Care Alliance, Seattle, WA
Seattle Cancer Care Alliance, Seattle, WA
11 February, 2018
Elihu Estey, MD, Seattle Cancer Care Alliance, Seattle, WA, discusses the design of clinical trials and treatment endpoints.
Drug Combinations and How Best to Develop New Drugs
Mark Levis, MD, PhD
Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD
Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD
11 February, 2018
Mark Levis, MD, PhD, of Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, gives an outline of drug combinations and how best to develop new treatment options.
Trial Design – An Industry Perspective
Jane Liang-White, PhD
Pfizer Inc., Groton, CT
Pfizer Inc., Groton, CT
11 February, 2018
Jane Liang-White, PhD, from Pfizer Inc., Groton, CT, presents a talk on trial design from an industry perspective.
